Methotrexate-Etoposide-Ifosfamide Compared with Doxorubicin-Cisplatin-Ifosfamide Chemotherapy in Osteosarcoma Treatment, Patients Aged 18-25 Years.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of adolescent and young adult oncology"
DOI: 10.1089/jayao.2019.0085
Abstract: Purpose: The French standard chemotherapy for osteosarcoma combines high-dose methotrexate (HDM) and etoposide-ifosfamide (EI) in children and adolescents, and API-AI (doxorubicin-cisplatin-ifosfamide) in adults. We herein present the results of M-EI and API-AI in 18- to… read more here.
Keywords: chemotherapy; etoposide ifosfamide; chemotherapy osteosarcoma; doxorubicin cisplatin ... See more keywords